Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants

项目4：暴露后生物标志物和放射性核素污染物的修复

• 批准号: 10589887
• 负责人: Rebecca J Abergel
• 金额: $ 51.49万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-03-10 至 2027-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10589887
• 关键词: Accidents; Acids; Actinoid Series Elements; Address; Adolescent; Animal Model; Animals; Area; Biochemistry; Biocompatible Materials; Biological; Biological Markers; Biology; Cardiovascular system; Cell physiology; Chelating Agents; Chemicals; Chemistry; Childhood; Complex; Data; Data Set; Dedications; Deposition; Development; Devices; Dose; Elements; Environment; Environmental Pollution; Environmental Risk Factor; Evaluation; Event; Excision; Exposure to; Female; Gene Expression; Gene Expression Alteration; Genes; Genetic; Health; Heavy Metals; Inhalation; Injections; Ions; Knowledge; Laboratories; Ligands; Literature; Lung; Medical; Meta-Analysis; Metals; Modeling; Molecular; Mus; Nuclear; Nuclear Reactor Accidents; Particulate; Plutonium; Population; Property; Radiation; Radiation Protection; Radiation Toxicity; Radiation induced damage; Radioactive; Radioisotopes; Radiology Specialty; Regulation; Research; Research Priority; Risk; Rodent Model; Sampling; Sex Differences; Signal Pathway; System; Terrorism; Therapeutic; Toxic effect; Toxicology; Treatment Efficacy; Treatment Protocols; Work; biomarker discovery; chelation; comparison control; design; dosimetry; drug development; epidemiologic data; experimental analysis; experimental study; exposed human population; functional genomics; improved; in vivo; interest; juvenile animal; male; mass casualty; mature animal; member; metal chelator; model development; nanoscale; novel therapeutics; particle; prevent; programs; remediation; respiratory; sample archive; sex; sex determination; specific biomarkers; tomography; tool; transcriptome; uptake

PROJECT 4: ABSTRACT In the last several years, a sense of urgency and a renewed interest in the study of radionuclide chemistry and biology have emerged, as threats of nuclear terrorism have become more plausible, as investigational medical tools have sought the radioactive properties of radionuclides, and as the risk of environmental contamination and human exposure to radioisotopes consequently increased. In this project, we will pursue the analysis of radionuclide distribution beyond the MACRO into the MESO, MICRO and NANO scales, in order to improve dosimetry modeling and biokinetics analyses, in line with biological endpoints, thereby enabling meaningful countermeasure development in the context of internal emitter exposures. The radiation damage and health risk presented by internalized radionuclides can be mitigated by the use of mitigators, such as decorporation agents, that reduce internal contamination. However, most effective agents enhance the elimination of only a limited range of radionuclides, and some are formulated in ways that would make administration in mass casualty situations challenging. Therefore, the development of improved decorporation therapies and better delivery systems for chelators is a research priority in the area of radiological and nuclear threat countermeasures. This project specifically addresses the urgent need to develop and implement an improved therapy for radioisotope contamination of a large population. It will establish biokinetic profiles in adult and juvenile animal models, enable the discovery of biomarkers of exposure, and extend the indication of a new therapeutic decorporation agent to selected radioisotopes in the form of inhaled particulates, by demonstrating the post-exposure potency of this product at preventing long-term lung deposition and subsequent damage. In addition, by correlating different biomarkers of radiation toxicity to countermeasure’s efficacy, this research will provide the foundational data needed to determine the need for, and course and endpoint of treatment.

项目 4：摘要 在过去的几年中，人们对放射性核素化学的研究产生了紧迫感和新的兴趣， 随着核恐怖主义的威胁变得更加可信，随着研究性医学的出现，生物学已经出现 工具已经寻找放射性核素的放射性特性，并作为环境污染的风险 人类接触放射性同位素的机会因此增加。在这个项目中，我们将进行分析。 放射性核素的分布超越宏观尺度，进入中观尺度、微观尺度和纳米尺度，以改善 剂量测定建模和生物动力学分析，符合生物学终点，从而实现有意义的 内部发射体暴露背景下的对策开发。 内化放射性核素引起的辐射可以通过使用缓和剂来减轻，例如去核剂， 然而，大多数有效的药剂只能增强有限的消除。 一系列放射性核素，其中一些的配制方式可以在大规模伤亡中进行管理 因此，开发改进的装饰疗法和更好的交付。 螯合剂系统是放射性和核威胁对策领域的研究重点。 该项目专门解决了开发和实施改进的放射性同位素疗法的迫切需要 它将在成年和幼年动物模型中建立生物动力学特征，使 暴露生物标志物的发现，并将新的治疗装饰剂的适应症扩展到 通过证明吸入颗粒形式的放射性同位素的暴露后效力 此外，通过关联不同的产品，可以预防长期肺部沉积和随后的损伤。 辐射毒性的生物标志物到对策的功效，本研究将提供基础数据 需要确定治疗的需要、疗程和终点。